Viridian Therapeutics (VRDN)
(Real Time Quote from BATS)
$17.22 USD
-0.07 (-0.41%)
Updated Jul 30, 2024 02:22 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.87 |
EPS Last Quarter | -0.79 |
Last EPS Surprise | 26.17% |
ABR | 1.38 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.61 |
Next Year | -3.86 |
EPS (TTM) | -4.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.08M | 0.08M | 0.23M | 0.68M |
# of Estimates | 3 | 3 | 5 | 2 |
High Estimate | 0.10M | 0.08M | 0.35M | 1.00M |
Low Estimate | 0.07M | 0.07M | 0.10M | 0.35M |
Year ago Sales | 0.07M | 0.07M | 0.31M | 0.23M |
Year over Year Growth Est. | 18.57% | 8.57% | -27.39% | 196.05% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.87 | -0.95 | -3.61 | -3.86 |
# of Estimates | 8 | 8 | 9 | 8 |
Most Recent Consensus | -0.83 | -0.86 | -3.37 | -3.87 |
High Estimate | -0.80 | -0.80 | -3.21 | -2.73 |
Low Estimate | -0.94 | -1.10 | -3.98 | -4.80 |
Year ago EPS | -1.27 | -1.09 | -5.31 | -3.61 |
Year over Year Growth Est. | 31.50% | 12.84% | 32.02% | -7.02% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.87 | -0.95 | -3.61 | -3.86 |
7 Days Ago | -0.87 | -0.95 | -3.61 | -3.94 |
30 Days Ago | -0.87 | -0.95 | -3.61 | -3.94 |
60 Days Ago | -0.87 | -0.95 | -3.61 | -3.84 |
90 Days Ago | -1.05 | -1.10 | -4.39 | -4.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.87 | -0.95 | -3.61 | -3.95 |
Zacks Consensus Estimate | -0.87 | -0.95 | -3.61 | -3.86 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -2.30% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.79 | -1.35 | -1.09 | -1.27 | NA |
Estimate | -1.07 | -1.08 | -1.22 | -1.26 | NA |
Difference | 0.28 | -0.27 | 0.13 | -0.01 | 0.03 |
Surprise | 26.17% | -25.00% | 10.66% | -0.79% | 2.76% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more